GLEN HJ STEVENS
Affiliation: Cleveland Clinic Foundation
- Antiepileptic therapy in patients with central nervous system malignanciesGlen H J Stevens
Brain Tumor Institute, Taussig Cancer Center R20, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Curr Neurol Neurosci Rep 6:311-8. 2006..This review mainly includes primary brain tumors, but most of the concepts are transferable to patients with metastatic tumors...
- Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastasesGregory M M Videtic
Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Int J Radiat Oncol Biol Phys 67:240-3. 2007..Clinical trials for patients with brain metastases generally exclude small-cell lung cancer (SCLC) cases. We hypothesize that the RPA classes are valid in the setting of SCLC brain metastases...
- Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary resultsRatna Sajja
Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic Foundation, OH 44195, USA
Technol Cancer Res Treat 4:675-82. 2005..A greater number of patients with longer follow-up after treatment may be needed to determine treatment variables predicting for long-term tumor control...
- Brain-invasive solitary fibrous tumor of the meninges: report of a caseElias A Castilla
Department of Anatomic Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Int J Surg Pathol 10:217-21. 2002..Focal infiltration into the underlying brain parenchyma was observed. The tumor was CD34 positive and EMA negative...
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the lateral ventricleTodd W Kelley
Division of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
Leuk Lymphoma 46:1423-7. 2005..This rare case provides insight into the pathophysiology of MALT lymphomas...
- Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiformeAimee L Quan
Department of Radiation Oncology, Brain Tumor Institute, The Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Int J Radiat Oncol Biol Phys 63:695-703. 2005..Further studies are needed to fully delineate the significance of this molecular marker in patients with GBM...
- New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium MeetingNancy D Doolittle
Department of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA
Clin Cancer Res 11:421-8. 2005..Transport across the BBB relates to the neurovascular unit, which consists not only of endothelial cells but also of pericyte, glia, and neuronal elements...
- Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective studySteven B Cannady
Department of Otolaryngology, Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Int J Radiat Oncol Biol Phys 58:253-8. 2004..The RTOG RPA classification system may be a useful tool in assessing prognosis in this patient population...
- Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesionsAndrew A Kanner
Brain Tumor Institute, The Cleveland Clinic, Ohio 44195, USA
Cancer 97:2806-13. 2003..Larger prospective studies may better determine the true specificity of S100beta as a marker for BBB function and as an early detection or follow-up marker of brain tumors...
- Gliomatosis cerebri: treatment results with radiotherapy aloneMohamed A Elshaikh
Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic Foundation, Ohio 44195, USA
Cancer 95:2027-31. 2002..Although brain radiotherapy controlled or stabilized disease progression in most patients, the overall survival after brain radiotherapy alone was not satisfactory. More aggressive therapy may be needed...
- Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphomaAnat Galor
Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Am J Ophthalmol 144:45-49. 2007..To report on the development of visually significant maculopathy associated with blood-brain barrier disruption (BBBD) therapy for the treatment of central nervous system (CNS) lymphoma...
- 5-Lipoxygenase inhibition as an adjuvant glioma therapyGlen Stevens; Fiscal Year: 2005..It would allow patients to "take charge" of their lives, which is itself a life enhancing experience and a major reason whv patients with GBM frequentlv use CAM therapies. ..